Legal & General Group’s Immune Design Corp. IMDZ Stock Holding History

Legal & General Group’s Portfolio IMDZ Stock Details IMDZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-5,795	Closed	-$34K	–	3532
2019 Q1	$34K	Hold	5,795	–	–	﹤0.01%	2882
2018 Q4	$8K	Hold	5,795	–	–	﹤0.01%	3300
2018 Q3	$20K	Hold	5,795	–	–	﹤0.01%	3210
2018 Q2	$26K	Hold	5,795	–	–	﹤0.01%	3090
2018 Q1	$19K	Hold	5,795	–	–	﹤0.01%	3128
2017 Q4	$23K	Buy	5,795 +2,278	+65%	+$12.4K	﹤0.01%	3127
2017 Q3	$36K	Buy	3,517 +1,311	+59%	+$12.9K	﹤0.01%	3022
2017 Q2	$22K	Hold	2,206	–	–	﹤0.01%	3164
2017 Q1	$15K	Hold	2,206	–	–	﹤0.01%	3150
2016 Q4	$13K	Buy	+2,206	New	+$15.6K	﹤0.01%	3193

Legal & General Group's IMDZ Position: Q2 2019 in Review

Legal & General Group sold out of Immune Design Corp. (IMDZ) in Q2 2019, closing a stake of 5,795 shares — an estimated $34K sold.

Legal & General Group first reported a position in IMDZ in Q4 2016 and held it in 10 quarters. The position peaked at $36K in Q3 2017. 0 funds tracked by Wall St. Rank hold IMDZ as of Q2 2019.

Legal & General Group reported no remaining Immune Design Corp. position as of Q2 2019 after selling out during the quarter.
Legal & General Group sold 5,795 Immune Design Corp. shares in Q2 2019, an estimated $34K.
Legal & General Group first reported a position in Immune Design Corp. in Q4 2016 and held it in 10 quarters.
Legal & General Group's Immune Design Corp. position peaked at $36K in Q3 2017.
0 funds tracked by Wall St. Rank held Immune Design Corp. as of Q2 2019.

Based on Legal & General Group's 13F filing for Q2 2019, filed 14 Aug 2019.